2018-11-01T10:59:00-05:00 2017-12-31 521855942 TATE AND TRYON 2021 L STREET NW SUITE 400 WASHINGTON DC 20036 990 2017-01-01 133905508 FOOD ALLERGY RESEARCH & EDUCATION INC FOOD 7036913179 7901 JONES BRANCH DRIVE NO 240 MCLEAN VA 221025303 LISA GABLE CEO 7036913179 2018-11-01 1 ELIZABETH HELLER P00397829 2022932200 216.59.105.130 2018-11-01 10:58:57 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 8B6C6DF7A8E3B84B5AE7D1943EC3750B5C691B8F 2017 2018-06-14 16:35:46Z X JAMES BAKER MD 7901 JONES BRANCH DRIVE NO 240 MCLEAN VA 221025303 13445311 0 X WWW.FOODALLERGY.ORG X 1998 NY FARE'S MISSION IS TO IMPROVE THE QUALITY OF LIFE AND THE HEALTH OF INDIVIDUALS WITH FOOD ALLERGIES, AND TO PROVIDE THEM HOPE THROUGH THE PROMISE OF NEW TREATMENTS. 19 18 61 1215 20450 -2440 11577982 12202169 159574 105977 -4946668 201479 -420642 -12376 6370246 12497249 2873428 3043514 0 0 5616459 6674970 0 0 2653286 3438742 4272508 11928629 13990992 -5558383 -1493743 57090740 55538497 5551809 5493309 51538931 50045188 X FOOD ALLERGY RESEARCH & EDUCATION (FARE) IS THE NATION'S LEADING ADVOCACY ORGANIZATION WORKING ON BEHALF OF THE 15 MILLION AMERICANS WITH FOOD ALLERGIES, INCLUDING ALL THOSE AT RISK FOR LIFE THREATENING ANAPHYLAXIS. FARE'S MISSION IS TO IMPROVE THE QUALITY OF LIFE AND THE HEALTH OF INDIVIDUALS WITH FOOD ALLERGIES, AND TO PROVIDE THEM HOPE THROUGH THE PROMISE OF NEW TREATMENTS. OUR WORK IS ORGANIZED AROUND THREE CORE TENETS: LIFE - SUPPORTING THE ABILITY OF INDIVIDUALS WITH FOOD ALLERGIES TO LIVE SAFE, PRODUCTIVE LIVES WITH THE RESPECT OF OTHERS THROUGH OUR EDUCATION AND ADVOCACY INITIATIVES; HEALTH - ENHANCING THE ACCESS OF INDIVIDUALS WITH FOOD ALLERGIES TO STATE-OF-THE ART DIAGNOSIS AND TREATMENT; AND HOPE - ENCOURAGING AND FUND RESEARCH IN BOTH INDUSTRY AND ACADEMIA THAT PROMISES NEW THERAPIES TO IMPROVE THE EVERYDAY LIVES OF THOSE LIVING WITH FOOD ALLERGIES. 0 0 4519406 2935492 SEE SCHEDULE ORESEARCH:FARE CLINICAL NETWORKTHE CORNERSTONE OF OUR EFFORTS WAS THE LAUNCH OF THE FARE CLINICAL NETWORK ('FCN') IN 2015 WITH 24 CENTERS OF EXCELLENCE ACROSS THE UNITED STATES. THE FCN SITES ARE CHANGING THE FACE OF FOOD ALLERGY RESEARCH BY RAISING THE QUALITY OF CARE FOR FOOD ALLERGIC PATIENTS NATIONWIDE, BY REDUCING DISCREPANCIES IN CARE AMONG PROVIDERS, AND BY MAKING COMPREHENSIVE CARE AVAILABLE FOR ALL PATIENTS WITH FOOD ALLERGIES. FCN SITES ARE HELPING PARENTS, CAREGIVERS AND PATIENTS IDENTIFY CENTERS THAT PROVIDE CLINICAL AND SUB-SPECIALTY FOOD ALLERGY SERVICES OF THE HIGHEST QUALITY AND THAT ARE LEADERS IN RAPIDLY APPLYING NEW EVIDENCE-BASED KNOWLEDGE. IMPORTANTLY, FCN CENTERS ARE ACCELERATING DRUG DEVELOPMENT FOR FOOD ALLERGY BY ENHANCING SITES' INFRASTRUCTURE AND CAPABILITIES TO PERFORM CRUCIAL LATE STAGE TRIALS AND PROVIDING THE BASIS FOR THE DEVELOPMENT AND GROWTH OF FARE'S NATIONAL FOOD ALLERGY PATIENT REGISTRY AND , EVENTUALLY, BIO-REPOSITORY. FARE ADDED FIVE NEW SITES IN 2016 AND AN ADDITIONAL THREE IN 2017. FARE'S ANNUAL INVESTMENT IN THE NETWORK IN 2017 WAS $2.2MM FOR 29 SITES (THREE SITES HAVE GONE INACTIVE SINCE INCEPTION DUE TO PERSONNEL CHANGES). THE ANNUAL INVESTMENT REPRESENTS FARE'S SUPPORT OF PART OF THE PRINCIPAL INVESTIGATOR'S SALARY AND THE SALARY OF A FULL-TIME RESEARCH COORDINATOR. AT YEAR-END 2017, THE FCN HAD 29 ACTIVE MEMBER SITES.FARE PATIENT REGISTRYON MAY 22, 2017, THE FARE PATIENT REGISTRY WAS LAUNCHED. THE REGISTRY WILL BE A VITAL TOOL THAT WILL HARNESS THE POWER OF PATIENT DATA TO ACCELERATE RESEARCH TOWARD REVEALING THE CAUSES OF FOOD ALLERGY, UNCOVERING, FOR EXAMPLE, WHY FOOD ALLERGY RATES HAVE INCREASED IN RECENT YEARS AND IDENTIFYING WHICH TREATMENTS MIGHT BE MOST EFFECTIVE FOR INDIVIDUAL FOOD ALLERGY PATIENTS. PATIENTS WITH FOOD ALLERGIES OR RELATIVES OF CHILDREN WITH FOOD ALLERGIES ARE ENCOURAGED TO PARTICIPATE IN THE REGISTRY AND HELP ADVANCE SCIENTIFIC DISCOVERIES BY ANONYMOUSLY SHARING THEIR MEDICAL HISTORIES WITH SCIENTISTS AND OTHERS. THIS IS A SIMPLE STEP THAT WILL PROVIDE CRITICALLY IMPORTANT DATA TO ASSIST RESEARCHERS IN MANY WAYS AND HELP INDIVIDUALS TRACK THEIR OWN CLINICAL HISTORIES. FARE'S PATIENT REGISTRY WILL COLLECT AND STORE DETAILED, DE-IDENTIFIED INFORMATION ABOUT PEOPLE WITH DIAGNOSED FOOD ALLERGIES. AMONG ITS MANY USES, THE REGISTRY DATABASE WILL BE A VALUABLE SOURCE OF DATA ON FOOD ALLERGY PREVALENCE, DEMOGRAPHY, MANAGEMENT AND OUTCOMES THAT CAN BE ACCESSED BY RESEARCHERS, CLINICIANS, CAREGIVERS, PHARMACEUTICAL COMPANIES AND OTHERS. IN ADDITION TO DATA PROVIDED BY PATIENTS, THE REGISTRY WILL HOUSE INFORMATION FROM DOCTORS AND HOSPITALS, INCLUDING THOSE IN THE FARE CLINICAL NETWORK, A COLLABORATIVE NETWORK OF 29 RESEARCH AND CLINICAL CARE INSTITUTIONS ACROSS THE COUNTRY.FARE'S PLANS FOR THE PATIENT REGISTRY INCLUDE A REPOSITORY OF BIOLOGICAL SAMPLES COLLECTED FROM FOOD ALLERGY PATIENTS AT PARTICIPATING CENTERS IN THE FARE CLINICAL NETWORK. DNA, RNA, BIOPSY AND SERUM SAMPLES WILL SPEED THE DISCOVERY OF SERUM BIOMARKERS, GENETIC RISK FACTORS AND ENVIRONMENTAL TRIGGERS OF FOOD ALLERGY. DATA WILL ASSIST FARE IN ITS ADVOCACY EFFORTS FOR REGULATORY APPROVAL OF TREATMENTS.PARTICIPATING PATIENTS WILL BE ABLE TO USE THE REGISTRY AS A FOOD ALLERGY MANAGEMENT TOOL TO HELP THEM KEEP RECORDS OF THEIR ALLERGIC REACTIONS, TRACK THE PROGRESSION OF THEIR DISEASE, AND CONNECT WITH CLINICAL TRIALS IN THEIR AREA. A PATIENT WOULD HAVE THE OPTION OF SHARING THIS DATA WITH HIS OR HER HEALTHCARE PROVIDERS. NEW INVESTIGATOR AND MID-CAREER AWARDSFARE IS ALSO COMMITTED TO MARKEDLY INCREASING THE NUMBER OF INVESTIGATORS IN THE FIELD THROUGH ITS INVESTIGATOR IN FOOD ALLERGY AWARD PROGRAM THAT WAS ALSO LAUNCHED IN 2015. THE PROGRAM IS DIVIDED INTO TWO CATEGORIES: NEW INVESTIGATOR AWARDS AND MID-CAREER AWARDS. THE INAUGURAL FARE INVESTIGATOR IN FOOD ALLERGY AWARDS WERE LAUNCHED AND FUNDED IN 2015. FARE LAUNCHED THE SECOND CYCLE OF THIS PROGRAM IN THE FALL OF 2016 (AND ANNOUNCED RECIPIENTS IN EARLY 2017). THE RECIPIENTS FOR THE FIRST CYCLE WERE:2015 NEW INVESTIGATOR RECIPIENTS ($75K ANNUALLY FOR 2 YEARS)1. JESSICA O'KONEK, PHD, UNIVERSITY OF MICHIGAN (ANN ARBOR) O'KONEK RESEARCHED THE MODULATION OF FOOD ALLERGY RESPONSES WITH NANOEMULSION-BASED ALLERGY VACCINES, EXPLORING THE POSSIBILITY OF PROVIDING PROTECTION AGAINST ANAPHYLAXIS WITH INTRANASAL ADMINISTRATION OF NANOEMULSION COMBINED WITH EGG OR PEANUT ANTIGENS.2. DUANE WESEMANN, MD, PHD, BRIGHAM AND WOMEN'S HOSPITAL (BOSTON) WESEMANN SEEKS TO IDENTIFY THE EXTENT TO WHICH PRIMARY IG REPERTOIRES CAN BE INFLUENCED BY MICROBIAL AND DIETARY EXPOSURES EARLY IN LIFE AND EXAMINE HOW MODIFICATION OF THESE EXPOSURES CAN REDUCE ALLERGIC RESPONSE TO FOOD.BOTH STUDIES CONCLUDED IN SEPTEMBER 2017.2015 MID-CAREER AWARD RECIPIENTS ($150K ANNUALLY FOR 5 YEARS)1. SIMON HOGAN, PHD, CINCINNATI CHILDREN'S HOGAN'S WORK FOCUSES ON IDENTIFYING THE KEY PROTEINS AND CELLS THAT CAUSE THE BLOOD VESSEL FLUID LEAK LEADING TO SEVERE ANAPHYLAXIS TRIGGERED BY FOODS. THIS KNOWLEDGE WILL HAVE IMPORTANT IMPLICATIONS FOR DEVELOPING NEW TREATMENT STRATEGIES AND THERAPEUTICS FOR PREVENTING THE DEVELOPMENT OF SEVERE, LIFE- THREATENING FOOD REACTIONS.2. MICHIKO OYOSHI, PHD, BOSTON CHILDREN'S HOSPITAL AND HARVARD MEDICAL SCHOOL OYOSHI IS EXAMINING THE ROLE OF MATERNAL ANTIBODIES TRANSFERRED TO BABIES THROUGH BREAST MILK IN INDUCING ORAL TOLERANCE IN CHILDREN. THIS STUDY MAY SUPPORT POTENTIAL BENEFICIAL EFFECTS OF MATERNAL ALLERGEN EXPOSURE DURING PREGNANCY AND LACTATION ON PROTECTING BABIES FROM FOOD ALLERGY.3. ERIK WAMBRE, PHD, BENAROYA RESEARCH INSTITUTE (SEATTLE) WAMBRE IS INVESTIGATING THE SPECIFIC T CELL RESPONSES TO PEANUT ALLERGIC COMPONENTS TO DETERMINE THE CELLULAR AND MOLECULAR MECHANISM ASSOCIATED WITH PEANUT SENSITIZATION, AS WELL AS THOSE THAT LEAD TO RESTORATION AND MAINTENANCE OF PROTECTIVE RESPONSES.2017 NEW INVESTIGATOR RECIPIENTS ($75K ANNUALLY FOR 2 YEARS)1. EDDA FIEBIGER, PHD, BOSTON CHILDREN'S HOSPITAL AND HARVARD MEDICAL SCHOOLDR. FIEBIGER IS EVALUATING WHETHER TREATMENTS TO INHIBIT A PROTEIN THAT IS ACTIVE DURING ALLERGIC REACTIONS MIGHT LEAD TO BETTER OUTCOMES FOR ORAL IMMUNOTHERAPY.2017 MID-CAREER AWARD RECIPIENTS ($150K ANNUALLY FOR 5 YEARS)1. ROBERT ANTHONY, PHD, MASSACHUSETTS GENERAL HOSPITAL AND HARVARD MEDICAL SCHOOL (BOSTON) DR. ANTHONY IS EXAMINING THE ROLE OF ANTIBODY GLYCOSYLATION - THE ADDITION OF SUGAR MOLECULES TO ANTIBODY PROTEINS - IN PROMOTING OR LIMITING ALLERGIC REACTIONS.2. STEPHANIE EISENBARTH, MD, PHD, YALE SCHOOL OF MEDICINEBY STUDYING A RARE, INHERITED SENSITIVITY TO FOOD ALLERGENS, DR. EISENBARTH IS SEARCHING FOR INSIGHT INTO MECHANISMS THAT UNDERLIE FOOD ALLERGIES IN THE GENERAL POPULATION. FARE ALSO SUPPORTS ESTABLISHED RESEARCHERS THROUGH FUNDING BASIC, CLINICAL AND EPIDEMIOLOGICAL RESEARCH AT SEVERAL SITES ACROSS THE COUNTRY.FARE CONTINUED ITS SUPPORT OF THE FOLLOWING RESEARCH STUDIES IN 2016 THAT WERE APPROVED IN PRIOR YEARS. PLEASE NOTE THAT FARE'S RESEARCH ADVISORY BOARD (RAB) NOT ONLY REVIEWS ALL GRANT APPLICATIONS IN A CONFLICT FREE MANNER, IT ALSO MONITORS PROGRESS RELATIVE TO MILESTONES CLOSELY FOR ALL GRANT AWARDS.1. EDWIN KIM, MD - U. NORTH CAROLINASECOND SITE: U. TEXAS SOUTHWEST (DREW BIRD, MD) STUDY: PEANUT SUBLINGUAL IMMUNOTHERAPY TRIALPREVIOUS STUDIES ON SUBLINGUAL IMMUNOTHERAPY (SLIT) AND ORAL IMMUNOTHERAPY (OIT) FOR PEANUT HAVE SHOWN THAT BOTH APPROACHES ARE ABLE TO DESENSITIZE MOST PATIENTS TO A DEGREE THAT IS LIKELY TO PREVENT ALLERGIC REACTIONS AFTER ACCIDENTAL INGESTION. HOWEVER, WHILE SLIT APPEARS TO BE FAR SAFER THAN OIT, IT PRODUCES A LESS ROBUST DESENSITIZATION EFFECT. THE LONG- TERM OBJECTIVE OF THIS STUDY IS TO DEVELOP A SAFE AND EFFECTIVE TREATMENT FOR PEANUT ALLERGY THAT WILL ENABLE PATIENTS TO DEVELOP TOLERANCE. TO THAT END, THIS STUDY OF 48 PATIENTS AIMS TO DETERMINE WHETHER 36 MONTHS OF TREATMENT WITH PEANUT SLIT WILL RESULT IN CLINICAL TOLERANCE. IT ALSO SEEKS TO DEFINE THE CHANGES IN THE BODY'S IMMUNE SYSTEM THAT LEAD TO TOLERANCE. DR. EDWIN KIM AND HIS TEAM HOPE THAT THIS STUDY WILL PROVIDE A STRONG SCIENTIFIC BASIS FOR THE DEVELOPMENT OF SLIT AND OTHER TREATMENTS THAT AIM TO PRODUCE LONG-TERM CLINICAL TOLERANCE TO PEANUTS AND OTHER FOODS. THIS STUDY IS ALSO BEING CONDUCTED AT UT SOUTHWESTERN MEDICAL CENTER IN DALLAS.STATUS: FULLY ENROLLED. IN ADDITION, FARE CONTINUED TO FUND THE ONGOING CLINICAL TRIAL FOR WALNUT OIT.THE RESULTS OF FARE-FUNDED RESEARCH STUDIES WERE PUBLISHED IN LEADING PEER-REVIEWED SCIENTIFIC JOURNALS, INCLUDING ALLERGY & ASTHMA PROCEEDINGS, ANNALS OF ALLERGY AND IMMUNOLOGY, JAMA PEDIATRICS, THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, AND THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE AND PRESENTED AT ACADEMIC MEETINGS IN THE UNITED STATES AND IN EUROPE.[CONTINUNED BELOW AT LINE 4D] 3817201 108022 85527 SEE SCHEDULE OEDUCATION AND ADVOCACY:EDUCATION:FARE CONDUCTED FOOD ALLERGY EDUCATION THROUGH BOTH NATIONAL AND REGIONAL EFFORTS. THESE EDUCATION PROGRAMS PROVIDED VITAL INFORMATION ON PREVENTING AND MANAGING FOOD ALLERGY REACTIONS, INCLUDING THE LIFE-THREATENING REACTION KNOWN AS ANAPHYLAXIS. FARE'S NATIONAL EDUCATION INITIATIVES PROVIDE INFORMATION FOR THOSE LIVING WITH FOOD ALLERGIES, AS WELL AS THOSE WHOSE WORK IS IMPACTED BY FOOD ALLERGIES AND THE PUBLIC.IN 2017, FARE PROVIDED FREE EDUCATIONAL INFORMATION THROUGH ITS WEBSITE (FOODALLERGY.ORG) AND BLOG, MAINTAINED AN ONGOING WEBINAR SERIES ON A VARIETY OF TOPICS RELATED TO FOOD ALLERGY MANAGEMENT, AND DISTRIBUTED KEY EDUCATIONAL MATERIALS SUCH AS "YOUR FOOD ALLERGY FIELD GUIDE," A COMPREHENSIVE RESOURCE FOR NEWLY DIAGNOSED PATIENTS. FARE ALSO HOSTED ITS ANNUAL TEEN SUMMIT, A NATIONAL GATHERING OF TEENS (AGES 11-22) WITH FOOD ALLERGIES, ALONG WITH THEIR PARENTS AND SIBLINGS; AND OUR NATIONAL FOOD ALLERGY CONFERENCE, WHICH BROUGHT TOGETHER INDIVIDUALS AND FAMILIES MANAGING FOOD ALLERGIES, CAREGIVERS, SCHOOL STAFF, AND HEALTH PROFESSIONALS- ADDING A LEARNING TRACK AND CONTINUING EDUCATION FOR SCHOOL NURSES - GIVING THEM AN OPPORTUNITY TO LEARN ABOUT ADVANCES IN FOOD ALLERGY RESEARCH AND ADVOCACY, BEST PRACTICES AND PRACTICAL SKILLS FOR LIVING WELL WITH FOOD ALLERGIES; AND THE INTERNATIONAL FOOD ALLERGY & ANAPHYLAXIS ALLIANCE MEETING, WHICH GATHERS LEADERS FROM PATIENT ADVOCACY ORGANIZATIONS ACROSS THE WORLD TO INFORM INTERNATIONAL POLICY ON FOOD ALLERGY RESEARCH, EDUCATION AND TREATMENT, ADVANCE FOOD ALLERGY AWARENESS, AND ENCOURAGE THE COMMERCIAL SECTOR TO SUPPORT THE FOOD ALLERGY COMMUNITY.FARE CONTINUED THE WORK OF ITS COLLEGE PROGRAM, LAUNCHING A NEW SEARCH TOOL TO PROVIDE MORE DETAILED AND SEARCHABLE INFORMATION ON ACCOMMODATIONS FOR STUDENTS WITH FOOD ALLERGIES ON COLLEGE CAMPUSES.IN 9 PILOT COMMUNITIES AROUND THE COUNTRY, FARE WORKED WITH THE COMMUNITY ENGAGEMENT COUNCILS. THE COUNCILS CONSIST OF GROUPS OF FOOD ALLERGY HEALTHCARE PROFESSIONALS, ADVOCATES, FAMILIES, AND VOLUNTEERS. THEIR WORK IS TO IMPROVE EDUCATION, OUTREACH, AND ADVOCACY EFFORTS LOCALLY. FARE ALSO PROVIDED 26 COMMUNITY FUNDING AWARDS TO LOCAL FOOD ALLERGY ADVOCATES AND GROUP LEADERS TO SUPPORT EDUCATION AND AWARENESS PROGRAMS IN THEIR LOCAL COMMUNITIES. THESE AWARDS AGAIN SERVED HUNDREDS OF FAMILIES ACROSS 20 STATES. ADVOCACY AND PUBLIC POLICY: FARE DEVOTED RESOURCES TO ADDRESSING A RANGE OF PUBLIC POLICY ISSUES THAT AFFECT AMERICANS WITH FOOD ALLERGIES AND THE ENTITIES THAT SERVE THEM. FARE CONTINUED TO PROVIDE INFORMATION AND SUBJECT MATTER EXPERTISE TO THE U.S. CONGRESS, FOOD AND DRUG ADMINISTRATION, THE U.S. DEPARTMENT OF AGRICULTURE, THE NATIONAL INSTITUTES OF HEALTH, AND A VARIETY OF PROFESSIONAL ASSOCIATIONS IN RELATED FIELDS. FARE CONTINUES TO LEAD EFFORTS TO EDUCATE ELECTED OFFICIALS AND KEY REGULATORS ABOUT THE IMPACT OF HIGH EPINEPHRINE AUTO-INJECTOR PRICES, OUT OF POCKET EXPENSES, AND OTHER INSURANCE ACCESS CHALLENGES ON MEMBERS OF THE FOOD ALLERGY COMMUNITY AND WORKED TO HIGHLIGHT SOLUTIONS TO IMPROVE COMPETITION, INNOVATION, ACCESS, AND AFFORDABILITY IN THE EPINEPHRINE MARKET, PARTICULARLY IN LIGHT OF RECALLS AND INVENTORY CONCERNS. WE ARE ALSO WORKING TO INTRODUCE PUBLIC POLICY THAT WOULD PROVIDE A VARIETY OF PROTECTIVE AND INCLUSIVE MEASURES FOR PEOPLE WITH FOOD ALLERGIES AT SCHOOL, AT WORK, WHILE TRAVELING, AND WHILE PURCHASING GROCERY PRODUCTS WITH ACCURATE LABELING INFORMATION.NATIONWIDE, FARE HAS BEEN INTEGRAL TO THE PASSAGE OF LAWS THAT ALLOW PUBLIC ENTITIES TO STOCK AUTO-INJECTABLE EPINEPHRINE IN 33 STATES AND SAW ELEVEN PIECES OF FOOD ALLERGY LEGISLATION PASS LAST YEAR. WE ALSO ORGANIZED SUCCESSFUL FOOD ALLERGY AWARENESS DAYS IN FOUR STATE CAPITALS (ANNAPOLIS (MD), AUSTIN (TX), BOSTON (MA), AND JEFFERSON CITY (MO) TO DEMONSTRATE SUPPORT FOR LEGISLATION.). FARE CONTINUED ITS COLLABORATIVE EFFORTS WITH ALLIED PROFESSIONALS BY PRESENTING AT CONFERENCES AND WORKING ON PROJECTS WITH FAIR HEALTH, THE NATIONAL CONFECTIONERS ASSOCIATION, THE CONFERENCE FOR FOOD PROTECTION, THE GROCERY MANUFACTURERS ASSOCIATION, FEEDING AMERICA, AND OTHERS. 2176142 SEE SCHEDULE OAWARENESS:THROUGH OUR PROGRAMS AND OUTREACH TO MEDIA NATIONWIDE, FARE HEIGHTENS AWARENESS OF FOOD ALLERGY AS A SIGNIFICANT AND GROWING PUBLIC HEALTH ISSUE THAT DEMANDS URGENT ATTENTION. IN 2017, FARE LAUNCHED THE REBRAND OF THE NATIONAL FOOD ALLERGY WALK, FARE'S FOOD ALLERGY HEROES WALK AND THE NEW COMMUNITY FOCUSED WALK PROGRAM, FARE'S HOMETOWN HEROES WALK. THE PROGRAMS BROUGHT TOGETHER SUPPORTERS IN 40 COMMUNITIES FOR FAMILY-FRIENDLY EVENTS FOCUSED ON SUPPORTING THE FOOD ALLERGY COMMUNITY'S CAUSE AND INCREASING AWARENESS OF FOOD ALLERGY AS A SERIOUS PUBLIC HEALTH ISSUE.IN MAY 2017, FARE CONTINUED ITS FOOD ALLERGY ACTION MONTH CAMPAIGN, WHICH EXPANDS THE TRADITIONAL AWARENESS WEEK INTO AN ENTIRE MONTH OF ACTIVITIES AND ACTIONS SUPPORTERS CAN TAKE TO HELP INCREASE UNDERSTANDING OF FOOD ALLERGIES AND MAKE A POSITIVE DIFFERENCE IN THE LIVES OF THOSE MANAGING THE DISEASE.IN SEPTEMBER AND OCTOBER 2017, FARE RAISED AWARENESS ABOUT FOOD ALLERGIES VIA ITS HIGH-PROFILE CAMPAIGN, THE TEAL PUMPKIN PROJECT, DESIGNED TO PROMOTE SAFETY, INCLUSION AND RESPECT OF INDIVIDUALS MANAGING FOOD ALLERGIES AND TO KEEP HALLOWEEN A FUN, POSITIVE EXPERIENCE FOR ALL. RESONATING WITH COMMUNITIES ACROSS THE COUNTRY AND AROUND THE WORLD, THE TEAL PUMPKIN PROJECT REACHED MORE THAN 5 MILLION USERS ON FACEBOOK, MORE THAN HALF A MILLION PEOPLE ON TWITTER, WAS COVERED BY HUNDREDS OF MEDIA OUTLETS, AND GARNERED PARTICIPATION FROM ALL 50 STATES, WASHINGTON, D.C., AND PUERTO RICO.IN THE DIGITAL SPACE, FARE'S AWARD-WINNING WEBSITE AND BLOG RECEIVED ALMOST 5 MILLION PAGE-VIEWS IN 2017, FARE'S BIMONTHLY E-NEWSLETTER REACHED MORE THAN 150,000 SUBSCRIBERS WITH EACH EDITION, AND FARE'S GROWING SOCIAL MEDIA PRESENCE REACHED MILLIONS OF USERS WITH IMPORTANT INFORMATION ABOUT FOOD ALLERGIES AND FARE PROGRAMS.IN 2017, FARE ISSUED 166 ALLERGY ALERTS AND INGREDIENT NOTICES. THE ALERTS PROVIDE INFORMATION ABOUT MISLABELED OR RECALLED FOOD AND THE INGREDIENT NOTICES ARE ADVANCE NOTIFICATIONS OF INGREDIENT CHANGES FROM FOOD COMPANIES. FOR FOOD ALLERGY FAMILIES, THIS IS CRITICAL INFORMATION TO RECEIVE IN ORDER TO PREVENT INADVERTENT REACTIONS. CONTINUATION OF 4A:PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE --EUGENE WASHINGTON PCORI ENGAGEMENT AWARD PROGRAMIN MAY 2016, FARE ANNOUNCED IT HAD RECEIVED THE EUGENE WASHINGTON ENGAGEMENT AWARD FROM THE PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI).FARE'S TWO-YEAR PROJECT, "EMPOWERING PATIENT PARTNERS AND KEY STAKEHOLDERS TO DEVELOP A PATIENT-CENTRIC FOOD ALLERGY RESEARCH PROGRAM," SEEKS TO ADDRESS AN UNMET NEED IN THE RESEARCH FIELD BY DEVELOPING A PARTNERSHIP OF PATIENTS EMPOWERED TO WORK WITH OTHER KEY STAKEHOLDERS, INCLUDING MEMBERS OF THE FARE CLINICAL NETWORK, TO DEVELOP A ROBUST PATIENT-CENTRIC FOOD ALLERGY RESEARCH PROGRAM INFORMED BY REAL-WORLD EXPERIENCES.FARE UNDERTOOK THIS INITIATIVE AT A CRITICAL TIME IN FOOD ALLERGY RESEARCH. THE ADVISORY BOARD IS INFLUENCING THE PROCESS OF SELECTING AND PRIORITIZING RESEARCH AND WILL HAVE INPUT INTO POTENTIAL CLINICAL TRIAL DESIGNS AND ENDPOINTS, THUS ENSURING THAT PATIENT-REPORTED OUTCOMES ARE CAPTURED.THE CORNERSTONE OF THIS PROJECT IS FARE'S NEW OUTCOMES RESEARCH ADVISORY BOARD, WHICH INCLUDES FOUR REGIONAL SUBGROUPS (MIDWEST, NORTHEAST MID-ATLANTIC, SOUTH, AND WEST) AND SEVERAL NATIONAL ADVISORS. FARE HAS CONSTITUTED THE OUTCOMES RESEARCH ADVISORY BOARD TO INCLUDE PATIENT REPRESENTATIVES (PARENTS OF CHILDREN WITH FOOD ALLERGIES OR ADULTS WITH FOOD ALLERGIES), RESEARCHERS, AND OTHER STAKEHOLDERS SUCH AS NURSES, EDUCATORS, ADVOCATES, HEALTH PLAN PAYERS AND PHARMACY BENEFIT MANAGERS. WORKING COLLECTIVELY, MEMBERS OF THE ADVISORY BOARD IS HELPING TO SHAPE FOOD ALLERGY RESEARCH INITIATIVES BY IDENTIFYING THEIR NEEDS, PREFERENCES AND PRIORITIES FOR RESEARCH-BASED INFORMATION OR EVIDENCE.2017 KEY ACCOMPLISHMENTS:1. REGIONAL AND NATIONAL CALLS/MEETINGSTHE FOUR REGIONAL BOARDS HELD QUARTERLY IN-PERSON OR TELEPHONIC FOCUS GROUP MEETINGS TO DISCUSS SURVEYS PRE AND POST 2016 RESEARCH RETREAT, TO DISCUSS DISSEMINATION AND IMPLEMENTATION INITIATIVES, AND TO PLAN FOR AND TO PROVIDE INPUT TO THE RESEARCH RETREAT HELD APRIL 13/14/2018 IN MCLEAN, VA2. DISSEMINATION AND IMPLEMENTATION ACCOMPLISHMENTS TO DATE, THE ORAB WORK HAS BEEN PRESENTED ATA. JMP SECURITIES CONFERENCE, 6/21/2017 NEW YORK, NYB. EAACI PATIENT ORGANIZATION COMMITTEE MEETING, 6/2017, HELSINKI, FINLANDC. INTERNATIONAL FOOD ALLERGY AND ANAPHYLAXIS MEETING, 10/25/17, LONDON, UKD. AMERICAN COLLEGE MEETING 10/26/17, BOSTON, MAE. FARE TEEN SUMMIT, 11/10-12/2017, NEWPORT BEACH, CAF. GORDON RESEARCH CONFERENCE (FOOD ALLERGY), 1/7-12/2018 VENTURA, CA3. ABSTRACTS WERE SUBMITTED FORA. ACAAI, 11/ 15-17/2018 (PLENARY SESSION), SEATTLE, WASHINGTONB. AAAAI, 2/2019, SAN FRANCISCO, CALIFORNIA4. NON- PEER REVIEWED ORAB AUTHORED ARTICLES INCLUDEA. OP ED WAS PUBLISHED ON SEPTEMBER 19 IN KEVINMD.COM; THE LINK IS HTTP://WWW.KEVINMD.COM/BLOG/2017/09/FOOD-ALLERGIES-PUBLIC-HEALTH-CRISIS-CAN-NO-LONGER-IGNORE.HTMLB. WORK WAS DISCUSSED AT LENGTH IN THE ALLERGIC LIVING (NOVEMBER 2017) ARTICLE ON THE INTERNATIONAL FOOD ALLERGY AND ANAPHYLAXIS MEETING5. WORKING GROUPS HAVE BEEN FORMED, AND WORK IS UNDERWAY, ADVOCACY, COMMUNITY ENGAGEMENT, AND ON THE FARE PATIENT REGISTRY 10512749 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 1 1 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 175 0 1 61 1 1 1 0 0 0 0 1 1 0 0 0 0 X 19 18 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AR CA CO CT FL GA IL KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC UT VA WA WV WI X X CALIBRE CPA GROUP 2023319880 7501 WISCONSIN AVENUE SUITE 1200 BETHESDA MD 20814 JANET ATWATER CHAIR 1.00 X X 0 0 0 ROB NICHOLS VICE-CHAIR 1.00 X X 0 0 0 MIKE LADE TREASURER 1.00 X X 0 0 0 DENISE BUNNING SECRETARY 1.00 X X 0 0 0 MARIA ACEBAL DIRECTOR 1.00 X 0 0 0 DAVID CROWN DIRECTOR 1.00 X 0 0 0 LEIGH FEUERSTEIN DIRECTOR 1.00 X 0 0 0 ANDY GILMAN DIRECTOR 1.00 X 0 0 0 JOHN HANNAN DIRECTOR 1.00 X 0 0 0 JOE IANNIELLO DIRECTOR 1.00 X 0 0 0 HELEN JAFFE DIRECTOR 1.00 X 0 0 0 REBECCA LAINOVIC DIRECTOR 1.00 X 0 0 0 SHARYN MANN DIRECTOR 1.00 X 0 0 0 ADAM MILLER DIRECTOR 1.00 X 0 0 0 ELISE PURCELL DIRECTOR 1.00 X 0 0 0 JOELLE RESNICK DIRECTOR 1.00 X 0 0 0 ROBERT L RICH DIRECTOR 1.00 X 0 0 0 JULIE WILCOX DIRECTOR 1.00 X 0 0 0 JAMES R BAKER CHIEF EXECUTIVE OFFICER 40.00 X X 533872 0 34643 SANDEEP DHAR CHIEF FINANCIAL OFFICER 40.00 X 285931 0 46844 MARY JANE MARCHISOTTO SVP RESEARCH 40.00 X 257921 0 25034 LOIS A WITKOP CHIEF ADVANCEMENT OFFICER 40.00 X 235039 0 8341 SCOTT RICCIO SVP EDUCATION & ADVOCACY 40.00 X 159359 0 17751 LANNY BROMFIELD CONTROLLER 40.00 X 144887 0 13944 1617009 0 146557 6 0 1 0 BEACONFIRE 2300 CLARENDON BLVD SUITE 92 ARLINGTON VA 22201 CONSULTING 384536 BLACKBAUD INC PO BOX 930256 ATLANTA GA 311930256 SOFTWARE LICENSES 203922 COLORNET PRINTING & GRAPHICS 22570 GLENN DR STERLING VA 20164 PRINTING, MAILINGS, STORAGE 153990 INVITAE CORPORATION 1400 16TH ST SAN FRANCISCO CA 94103 PATIENT REGISTRY IMPLEMENTATION, SURVEY, 135000 CHARITY DYNAMICS LLC 4031 GUADALUPE ST AUSTIN TX 78751 CONSULTING, LICENSE FEES 132264 16 33760 2770538 87955 9309916 1401886 12202169 EDUCATIONAL PROGRAMS 900099 85527 85527 ADVERTISING 541800 20450 20450 105977 201479 201479 11246 11246 869 0 869 869 869 813244 2770538 913692 -100448 -100448 28350 2547 25803 25803 64955 31823 33132 33132 OTHER INCOME 900099 17022 17022 17022 12497249 118659 20450 155971 X 3043514 3043514 1628521 1169420 125504 333597 4144691 2978687 319553 846451 131569 95516 9500 26553 380588 269695 29717 81176 389601 281116 27040 81445 177395 52974 5189 119232 25384 1417 19942 4025 32750 32750 186500 186500 1607380 1270832 23079 313469 172742 87748 25 84969 480338 219048 20329 240961 510776 163512 63905 283359 428878 210300 106704 111874 529794 430290 16601 82903 23047 12457 6399 4191 65386 35341 18156 11889 MAIL SHOP FEES 26638 1619 7 25012 MISC. EXPENSES 5500 2763 557 2180 13990992 10512749 824957 2653286 X 1109064 795081 0 313983 2710529 1995826 52224765 48035562 1841234 5122649 12160 12805 29967 28796 178426 193632 230554 170262 62138 60292 31521 88935 57090740 55538497 817518 1397809 4639600 4031407 94691 64093 5551809 5493309 X 45031650 40298373 6507281 9746815 51538931 50045188 57090740 55538497 -1493743 0 X X 0 1 X 1 0 X 15724060 13005978 12086613 11577982 12202169 64596802 15724060 13005978 12086613 11577982 12202169 64596802 13935280 50661522 15222 7932 25847 94079 213594 356674 17022 17022 64970498 2129129 0.77980 0.76980 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME 186500 186500 14752554 14939054 896953 224238 0 0 739676 1000000 793806 896953 3430435 5145653 152250 94125 99500 186500 532375 184919 250000 198452 224238 857609 1286414 37748 13838 23910 179276 142894 36382 13530 13530 0 60292 DEFERRED RENT 64093 64093 13445310 948061 948061 12497249 0 12497249 14939053 948061 948061 13990992 0 13990992 PART XI, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD 31,823. DIRECT FUNDRAISING EXPENSES 916,238. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD 31,823. DIRECT FUNDRAISING EXPENSES 916,238. GALA 1998595 1886042 112553 1450 188769 277727 LUNCH 900701 839051 61650 27538 55000 82847 139763 14 684486 45445 639041 7295 4846 43371 85086 3583782 2770538 813244 36283 59846 314987 502576 913692 -100448 28350 2547 1 0.85000 28350 2547 2547 25803 NY 1 0 1 0 1.00000 ANNE HORNING 515 MADISON AVENUE SUITE 1912 NEW YORK NY 10022 0 0 1 ACHRI 13 CHILDRENS WAY LITTLE ROCK AR 72202 710694931 501 ( C ) 3 90000 FARE CLINICAL NETWORK BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON 1201 NINTH AVENUE SEATTLE WA 981012795 910653422 501 ( C ) 3 70000 FARE CLINICAL NETWORK CHILDREN'S HOSPITAL CORP (DBA BOSTON CHILDREN'S HOSP) (FIEBIGER) 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501 ( C ) 3 150000 RESEARCH CHILDREN'S HOSPITAL LOS ANGELES 4650 SUNSET BOULEVARD MS 75 LOS ANGELES CA 90027 951690977 501 ( C ) 3 70000 FARE CLINICAL NETWORK CHILDREN'S NATIONAL MEDICAL CENTER 111 MICHIGAN AVE NW WASHINGTON DC 20010 521640403 501 ( C ) 3 70000 FARE CLINICAL NETWORK CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 3333 BURNET AVEM ML 7030 CINCINNATI OH 452293039 310833936 501 ( C ) 3 90000 FARE CLINICAL NETWORK COLUMBIA UNIVERSITY MEDICAL CENTER 630 W 138TH STREET PH8E0101B NEW YORK NY 10032 135598093 501 ( C ) 3 35000 FARE CLINICAL NETWORK ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI BOX 1198 ONE GUSTAVE L LEVY PLACE NEW YORK NY 100296574 136171197 501 ( C ) 3 120000 FARE CLINICAL NETWORK ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI BOX 1198 ONE GUSTAVE L LEVY PLACE NEW YORK NY 100296574 136171197 501 ( C ) 3 25000 RESEARCH INDIANA UNIVERSITY 11725 N ILLINOIS STREET CARMEL IN 46032 356001673 501 ( C ) 3 35000 FARE CLINICAL NETWORK LURIE CHILDREN'S HOSPITAL OF CHICAGO 225 E CHICAGO AVE CHICAGO IL 60611 362170833 501 ( C ) 3 90000 FARE CLINICAL NETWORK MASSACHUSETTS GENERAL HOSPITAL 175 CAMBRIDGE STREET BOSTON MA 02114 042697983 501 ( C ) 3 450000 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 175 CAMBRIDGE STREET BOSTON MA 02114 042697983 501 ( C ) 3 90000 FARE CLINICAL NETWORK NATIONAL JEWISH HEALTH 1400 JACKSON STREET DENVER CO 80206 742044647 501 ( C ) 3 90000 FARE CLINICAL NETWORK NORTHWEST ALLERGY AND ASTHMA CENTER 9725 3RD AVE NE SUITE 500 SEATTLE WA 98115 237219813 501 ( C ) 3 70000 FARE CLINICAL NETWORK NORTHWEST ASTHMA & ALLERGY 9725 3RD AVE NE SUITE 500 SEATTLE WA 98115 237219813 501 ( C ) 3 12371 RESEARCH RADY CHILDREN'S HOSPITAL UNIVERSITY OF CALIFORNIA 9500 GILMAN DRIVE 0934 LA JOLLA CA 92093 956006144 501 ( C ) 3 90000 FARE CLINICAL NETWORK REGENTS OF THE UNIVERSITY OF MICHIGAN 500 S STATE ST ANN ARBOR MI 48109 386006309 501 ( C ) 3 70000 FARE CLINICAL NETWORK SPECIALLY FOR CHILDREN 1301 BARBARA JORDAN BOULEVARD SUITE 200 AUSTIN TX 78723 742800601 501 ( C ) 3 70000 FARE CLINICAL NETWORK STANFORD UNIVERSITY 3160 PORTER DRIVE PALO ALTO CA 94304 911156365 501 ( C ) 3 120000 FARE CLINICAL NETWORK THE CHILDREN'S HOSPITAL OF PHILADELPHIA 3401 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352166 501 ( C ) 3 90000 FARE CLINICAL NETWORK THE UNIVERSITY OF CHICAGO 5801 S ELLIS AVE CHICAGO IL 60637 362177139 501 ( C ) 3 52500 FARE CLINICAL NETWORK UNIVERSITY OF ARIZONA PO BOX 210017 TUSCON AZ 85721 742652689 501 ( C ) 3 70000 FARE CLINICAL NETWORK UNIVERSITY OF CALIFORNIA LOS ANGELES CENTER 110000 KINROSS AVENUE SUITE 211 LOS ANGELES CA 900951406 956006143 501 ( C ) 3 70000 FARE CLINICAL NETWORK UNIVERSITY OF NORTH CAROLINA 260 MACNIDER CB7220 CHAPEL HILL NC 27599 566001393 501 ( C ) 3 90000 FARE CLINICAL NETWORK UNIVERSITY OF ROCHESTER 601 ELMWOOD AVENUE BOX 777 ROCHESTER NY 14642 160743209 501 ( C ) 3 70000 FARE CLINICAL NETWORK UNIVERSITY OF SOUTH FLORIDA 3702 SPECTRUM BLVD SUITE 165 TAMPA FL 336129445 593102112 501 ( C ) 3 83333 FARE CLINICAL NETWORK UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD DALLAS TX 75390 756002868 501 ( C ) 3 13969 FARE CLINICAL NETWORK YALE UNIVERSITY 25 SCIENCE PARK 3RD FLOOR OFFICE SPONSORED PROJECTS NEW HAVEN CT 065208237 060646973 501 ( C ) 3 450000 RESEARCH ST NORBERT COLLEGE 100 GRANT ST DEPT 47 DE PERE WI 54115 391399196 501 ( C ) 3 10000 EDUCATION GRANT STANFORD UNIVERSITY RDE STANFORD DINING 693 PAMPAS LN STANFORD CA 943057010 941156365 501 ( C ) 3 10000 EDUCATION GRANT ANAPHYLAXIS & FOOD ALLERGY ASSOCIATION OF MN 970 RAYMOND AVENUE SUITE G-40 ST PAUL MN 55114 050585572 501 ( C ) 3 8500 EDUCATION GRANT UTAH FOOD ALLERGY NETWORK PO BOX 1066 DRAPER UT 84020 208914771 501 ( C ) 3 6500 EDUCATION GRANT 29 0 PART I, LINE 2: THERE IS A FORMAL GRANT REVIEW PROCESS. ALL DISBURSEMENTS ARE DOCUMENTED. GRANTEES ARE REQUIRED TO WRITE ANNUAL UPDATES ON THEIR PROGRESS AS WELL AS GOALS ACHIEVED. FUTURE GRANT AWARDS ARE CONTINGENT UPON ACHIEVEMENT OF SPECIFIC MILESTONES. X X X 0 0 0 0 0 0 0 1 0 JAMES R BAKER CHIEF EXECUTIVE OFFICER 406892 0 125000 0 1980 0 8100 0 33671 0 575643 0 0 0 SANDEEP DHAR CHIEF FINANCIAL OFFICER 219616 0 65625 0 690 0 8100 0 46138 0 340169 0 0 0 MARY JANE MARCHISOTTO SVP RESEARCH 178312 0 77629 0 1980 0 7807 0 20859 0 286587 0 0 0 LOIS A WITKOP CHIEF ADVANCEMENT OFFICER 234627 0 0 0 412 0 6914 0 3390 0 245343 0 0 0 SCOTT RICCIO SVP EDUCATION & ADVOCACY 159115 0 0 0 244 0 4514 0 16910 0 180783 0 0 0 LANNY BROMFIELD CONTROLLER 122459 0 21038 0 1390 0 4380 0 11650 0 160917 0 0 0 PART I, LINE 7 BONUSES ARE PROVIDED TO ENSURE THAT KEY EMPLOYEES WHO PERFORM WELL ARE RECOGNIZED FOR THEIR PERFORMANCE AND RETAINED BY FARE. THE PERFORMANCE OF THESE EMPLOYEES WAS REVIEWED BY MANAGEMENT, INCLUDING THE CEO, AND BONUSES WERE AWARDED APPROPRIATELY. OTHER REPORTABLE COMPENSATION INCLUDES SEVERANCE PAY, RELOCATION, AND TRANSITION COSTS. X 1 5000 FMV X 1005 FMV X 11 1365603 FMV X PHOTOGRAPHY PACKAGES 5 11300 FMV X ADVERTISING 2 6000 FMV X VACATION PACKAGES 2 5195 FMV X FOOD/RESTAURANT GIFT CERT 5 2350 FMV X FASHION/BEAUTY PACKAGES 5 1886 FMV X OTHER MISCELLANEOUS 4 1805 FMV X FITNESS/GYM 2 1110 FMV X SPORTS/SHOWS 1 560 FMV X JEWELRY 1 72 FMV 0 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF FORM 990 IS SENT TO THE BOARD FOR REVIEW BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS AND TRUSTEES ANNUALLY SIGN A FOOD ALLERGY RESEARCH & EDUCATION MANAGEMENT AND STAFF DISCLOSURE STATEMENT WHICH AFFIRMS THAT THEY HAVE RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY, HAVE READ AND UNDERSTAND IT, AND HAVE AGREED TO COMPLY WITH THE POLICY. IF A CONFLICT OF INTEREST IS DISCLOSED, THE AFFECTED PARTY WILL DISCUSS THE ISSUE WITH THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS WILL DISCUSS THE ISSUES, CONSULT AN ATTORNEY IF NECESSARY, AND TAKE APPROPRIATE ACTION. APPROPRIATE DISCIPLINARY ACTION WILL BE IMPOSED AGAINST ANY PERSON VIOLATING THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION USES COMPARABLE DATA IN THE INDUSTRY TO DETERMINE COMPENSATION AND COMPENSATION IS VOTED AND AGREED UPON BY THE GOVERNING BODY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. ANY OTHER DOCUMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 1,270,582. MANAGEMENT AND GENERAL EXPENSES -135,211. FUNDRAISING EXPENSES 259,808. TOTAL EXPENSES 1,395,179. PHOTOGRAPHY: PROGRAM SERVICE EXPENSES 250. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 3,525. TOTAL EXPENSES 3,775. TEMP AGENCY FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 8,696. FUNDRAISING EXPENSES 4,136. TOTAL EXPENSES 12,832. RECRUITMENT: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 149,594. FUNDRAISING EXPENSES 46,000. TOTAL EXPENSES 195,594. FORM 990, PART XII, LINE 2C THE AUDIT OVERSIGHT PROCESS HAS REMAINED UNCHANGED FROM THE PRIOR YEAR.